Xtant Medical Holdings (XTNT) announced Monday morning that it has received 510(k) clearance from the FDA for InTice-C Porous Titanium Cervical Interbody System.
Xtant Medical gapped open sharply higher this morning and is now up 1.00 at $6.95. The stock has risen to nearly a 2-week high.
For comments and feedback contact: editorial@rttnews.com
Business News